TipRanks
Advertisement
Advertisement
Danaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi
PremiumThe FlyDanaher’s IDT, Aldevron launch research grade S.p. Cas9 mRNA, SpyFi
15d ago
Danaher assumed with a Buy at UBS
Premium
The Fly
Danaher assumed with a Buy at UBS
23d ago
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
Premium
The Fly
Wells sees Repligen among key beneficiaries of Moderna’s cancer vaccine data
1M ago
Danaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
PremiumRatingsDanaher: Temporary Bioprocessing Setback, Structural Story Intact; Buy Rating and $220 Price Target Reiterated
2M ago
Danaher’s recent volatility presents buying opportunity, says Argus
Premium
The Fly
Danaher’s recent volatility presents buying opportunity, says Argus
2M ago
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
Premium
Ratings
Goldman’s Koslosky Reiterates Buy on Danaher as Q2 Beat and Tools Recovery Offset Trimmed 2024 Core Growth Guidance
2M ago
Danaher price target lowered to $220 from $260 at Stifel
PremiumThe FlyDanaher price target lowered to $220 from $260 at Stifel
2M ago
Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength
Premium
Ratings
Danaher: Analyst Reaffirms Buy, Lifts Price Target to $255 on Long-Term Bioprocessing Upside and Life Sciences Strength
2M ago
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
Premium
Ratings
Margin Resilience and Life Science Recovery Support Buy Rating as Danaher Price Target Remains Unchanged at $230
2M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―